First Western Trust Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

First Western Trust Bank’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$420K	Hold	544	–	–	0.02%	143
2025 Q4	$420K	Hold	544	–	–	0.02%	137
2025 Q3	$306K	Sell	544 -1	-0.2%	-$565	0.01%	155
2025 Q2	$286K	Buy	545 +33	+6%	+$18.4K	0.01%	158
2025 Q1	$325K	Buy	512 +37	+8%	+$25.4K	0.02%	146
2024 Q4	$338K	Sell	475 -39	-8%	-$32.7K	0.02%	151
2024 Q3	$540K	Buy	514 +51	+11%	+$56.8K	0.02%	122
2024 Q2	$487K	Hold	463	–	–	0.02%	120
2024 Q1	$446K	Hold	463	–	–	0.02%	132
2023 Q4	$407K	Hold	463	–	–	0.02%	142
2023 Q3	$381K	Sell	463 -1	-0.2%	-$786	0.02%	131
2023 Q2	$333K	Sell	464 -13	-3%	-$10K	0.02%	147
2023 Q1	$392K	Hold	477	–	–	0.02%	140
2022 Q4	$344K	Hold	477	–	–	0.02%	140
2022 Q3	$329K	Hold	477	–	–	0.02%	127
2022 Q2	$285K	Sell	477 -4	-0.8%	-$2.6K	0.02%	145
2022 Q1	$333K	Buy	+481	New	+$304K	0.02%	149

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Western Trust Bank's REGN Position: Q1 2026 in Review

First Western Trust Bank held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 544 shares worth $420K. The position accounts for 0.02% of the portfolio, ranked #143.

First Western Trust Bank first reported a position in REGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $540K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

First Western Trust Bank held 544 shares of Regeneron Pharmaceuticals worth $420K as of Q1 2026.
First Western Trust Bank left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
Regeneron Pharmaceuticals made up 0.02% of First Western Trust Bank's portfolio in Q1 2026, its #143 holding.
First Western Trust Bank first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
First Western Trust Bank's Regeneron Pharmaceuticals position peaked at $540K in Q3 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on First Western Trust Bank's 13F filing for Q1 2026, filed 12 May 2026.